Navidea Biopharmaceuticals Company

Navidea Biopharmaceuticals is a leader in precision medicine with immuno-targeted products designed to help identify the sites.
Technology: Personalised Medicine
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States
Founded Date: 1983-01-01
Employees Number: 11-50
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 2
Total Funding: $92.5M
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership